ADAPTIMMUNE THERAPEUTICS PLC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 7.01 Regulation FD Disclosure.

On November 20, 2020, Adaptimmune Therapeutics plc issued a press release summarizing the topics to be presented today at the Company's virtual Investor Day. After the event, a copy of the presentation materials and webcast links will be available through the Investors section of the Company's website at https://www.adaptimmune.com/investors-and-media. The information contained on the Company's website is not part of this Form 8-K and is not incorporated by reference into this Form 8-K.

The press release is furnished as Exhibit 99.1 and is incorporated by reference herein.

The information in this Item 7.01, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d)  Exhibits.

Exhibit No.                           Description of Exhibit

   99.1          Press release dated November 20, 2020

    104        Cover Page Interactive Date File (embedded within the Inline XBRL
               document)

© Edgar Online, source Glimpses